$PMGC Holdings (ELAB.US)$
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation
Monday, 9th December at 8:00 am
• EL-22, a first-in-class myostatin asset, is being developed as a potential combination therapy with GLP-1 receptor agonists for obesity. It aims to address muscle loss, a common side effect of rapid weight loss from GLP-1-based treatments, by preserving muscle mass wh...

$XRP (XRP.CC)$ just sold my kidney for xrp

Note: This seems to be a long list. The rationale is that I al focused on at least 20% gains and not just after bangers. My trading style is to compound those 10-15-20-30% earnings and roll all profit rather than waiting for runners everyday. If runners appear, then I’ll grab it as well. Each has his own style earning.
$Damon Inc (DMN.US)$ Can be my  PM gapper. Low float EV stock. IPO las...

$NVIDIA (NVDA.US)$ $Advanced Micro Devices (AMD.US)$
Donald Trump made raising tariffs on imported goods a tenet of his reelection campaign. And while that could raise prices on everything from jeans to children's toys for everyday Americans, Trump has also floated the idea of another tariff that could impact Wall Street's current favourite trade: AI.
During an appearance on Joe Rogan's podcast ahead of the elect...

$TC BioPharm (TCBP.US)$
TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant
TC BioPharm has been awarded a $250,000 non-dilutive grant from ScaleReady's G-Rex® Grant Program to support TCB008 manufacturing process optimizations over the next 18 months. The company aims to increase yields while reducing manufacturing costs by over 80%. The grant will help expedite process optimizations, allowing for expanded yields with a shortened manufacturing process in the first half of 2025, whic...